TGFB1 and metastatic malignant neoplasm: In particular, the interaction between metastatic cancer-2 cells and mCAFs was the most frequent, and the ligand-receptor pairs were enriched in various cancer-related pathways, including the Notch, Wnt, and TGF-β pathways (Fig. S4).